Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
462.12B
Market cap462.12B
Price-Earnings ratio
18.52
Price-Earnings ratio18.52
Dividend yield
2.65%
Dividend yield2.65%
Average volume
8.66M
Average volume8.66M
High today
$191.88
High today$191.88
Low today
$191.88
Low today$191.88
Open price
$193.01
Open price$193.01
Volume
3.49K
Volume3.49K
52 Week high
$194.48
52 Week high$194.48
52 Week low
$140.68
52 Week low$140.68

JNJ News

Simply Wall St 11h
Promising Amivantamab Injection Data Might Change the Case for Investing in Johnson & Johnson

Johnson & Johnson recently announced promising results from its Phase 1b/2 OrigAMI-4 study, demonstrating that the new subcutaneous formulation of amivantamab a...

Promising Amivantamab Injection Data Might Change the Case for Investing in Johnson & Johnson
The Motley Fool 16h
Johnson & Johnson Draws Long-Term Buyers as Markets Turn Cautious

Image source: Getty Images On October 16, 2025, CADINHA & CO LLC disclosed a buy of 91,615 Johnson & Johnson shares, an estimated $15.70 million trade based on...

Johnson & Johnson Draws Long-Term Buyers as Markets Turn Cautious
Nasdaq 24h
JNJ Quantitative Stock Analysis

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor mod...

JNJ Quantitative Stock Analysis

Analyst ratings

59%

of 27 ratings
Buy
59.3%
Hold
33.3%
Sell
7.4%

More JNJ News

TipRanks 1d
Top Johnson & Johnson Executive Cashes In on Multi-Million Dollar Stock Sale!

New insider activity at Johnson & Johnson ( (JNJ) ) has taken place on October 20, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 2d
Bicara Therapeutics: Strategic Advantages and Favorable Safety Profile Drive Buy Rating

Analyst Soumit Roy from JonesTrading reiterated a Buy rating on Bicara Therapeutics Inc. and keeping the price target at $27.00. Elevate Your Investing Strategy...

Simply Wall St 3d
Evaluating Johnson & Johnson’s Value After Recent FDA Approval and Strong Price Rally

If you've been watching Johnson & Johnson stock lately, you're probably wondering if now is the time to make a move or wait for a better entry point. With share...

Evaluating Johnson & Johnson’s Value After Recent FDA Approval and Strong Price Rally
TipRanks 3d
Johnson & Johnson announces new results from Phase 1b/2 OrigAMI-4 study

Johnson & Johnson announced new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous, SC, amivantamab monotherapy in p...

Nasdaq 3d
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026

Key Points Kenvue is battling a barrage of ailments. The company has a new leadership team to help turn things around. Multiple catalysts could drive a recov...

Meet the 5%-Yielding Dividend Stock That Could Soar in 2026
Nasdaq 3d
Guru Fundamental Report for JNJ

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Shareholder Yield Inves...

Guru Fundamental Report for JNJ
Simply Wall St 4d
Johnson & Johnson: Exploring Valuation After Recent Share Price Gains

Johnson & Johnson (JNJ) shares have been drawing attention as investors consider recent trends in healthcare stocks, especially in light of the company’s stable...

Johnson & Johnson: Exploring Valuation After Recent Share Price Gains

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.